The DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
Detection of on-target and off-target mutations generated by CRISPR/Cas9 and other sequence-specific nucleases
Open accessAbstract
The development of customizable sequence-specific nucleases such as TALENs, ZFNs and the powerful CRISPR/Cas9 system has revolutionized the field of genome editing. The CRISPR/Cas9 system is particularly versatile and has been applied in numerous species representing all branches of life. Regardless of the target organism, all researchers using sequence-specific nucleases face similar challenges: confirmation of the desired on-target mutation and the detection of off-target events. Here, we evaluate the most widely-used methods for the detection of on-target and off-target mutations in terms of workflow, sensitivity, strengths and weaknesses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Delivery methods improvement | Application in vivo [95–105] | LNP: Can be quickly degraded in vivo | Eliminate off-target effects |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Delivery methods improvement | Application in vivo [95–105] | AAV: Last for years in terminally differentiated cell types | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When the indels are deposited at the coding sequences of a given gene, NHEJ can cause frameshift mutations, resulting in non-sense-mediated mRNA decay and gene silencing (Wang et al., 2016a; Zischewski et al., 2017; Lindeboom et al., 2019).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Zischewski et al., 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“| Delivery methods improvement | Application in vivo [95–105] | LNP: Can be quickly degraded in vivo | Eliminate off-target effects |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [103]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“| Delivery methods improvement | Application in vivo [95–105] | AAV: Last for years in terminally differentiated cell types | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
Flagged first, then by citations
2 of the 78 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–321 of 321
Impact of the environment on milk production and aspects of its constituents for human consumption
Diwakar, V., Goli, R. C., Kumar, P., & Kumar, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24820-7.00054-7
Structure-activity relationships study on inhibition of CRISPR-Cas9 by glycosaminoglycans
Cheng, Y., Wang, Z., Cao, M., Liu, S., Zhang, X., Cheng, C., Cai, C., Zhang, X., & Zheng, J. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123912
High-throughput Metabolomics for Assessing CRISPR-edited Plants
Keot, A. K., Sarki, Y. N., Marwein, R., Chikkaputtaiah, C., & Singha, D. L. (2025) · CABI biotechnology series. · doi:10.1079/9781800626911.0014
Detection of mutations induced by CRISPR /Cas9 in cabbage protoplasts using qPCR and dPCR
Stajič, E., Javornik, Ž., & Štajner, N. (2025) · Annals of Applied Biology · doi:10.1111/aab.70048
Waglawala, S. F., Singh, D. K., & Das, S. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-5646-4.ch014
Role of gene therapy and immunotherapy in precision medicine
Khan, I. A., Khatun, H., & Viswa, P. D. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33302-6.00011-1
Mandal, S., Hazra, S., Syed, R., Chetri, A., Upadhyay, D. K., Samanta, E., Vats, K., & Thakur, H. (2026) · Sustainability Sciences in Asia and Africa · doi:10.1007/978-981-95-6722-5_9
ADAM9 in tumor biology: molecular functions, clinical implications, and therapeutic targeting
Ho, K., Wu, C.-J., Yang, Y., & Chien, M. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00910-2
Molecular characterization and functional analysis of poor-prognosis B-cell leukemias
Bougacha, N. (2019) · theses.fr (ABES) · doi:10.70675/86f73dd3z982dz4a64z9670zd4291a5714a3
Drug delivery nanosystems for skeletal muscle treatment in myotonic dystrophy
Repellin, M. (2022) · theses.fr (ABES) · doi:10.70675/905c40e8z03bdz417fz889dzf4930211a75b
Next-Generation Sequencing for Plant Genomics
Mishra, G., Srivastava, T., Sukirti, Mohapatra, S. R., Ashwath, M. N., & Ankita (2026) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-92-0533-2_1
Applications of CRISPR-Cas9 Gene Editing Technology in Food Allergy Therapy: A Comprehensive Review
Khalil, A. M. (2026) · Recent Progress in Science and Engineering · doi:10.21926/rpse.2602009
Köse, A. M., Ranalli, M., Trivanović, D. I., & Maslovarić, I. S. (2026) · Biotechnology and Bioengineering · doi:10.1002/bit.70279
CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria
Zubair, A., Hemal, M. A. K. P., Ahmed, A., Ahmad, F., Waheed, Y., & Afghan, N. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05118-8
Sharma, N. N., Kumari, A., Vashisht, I., & Sharma, M. K. (2026) · Plant Cell Reports · doi:10.1007/s00299-026-03956-w
Microalgal proteins as sustainable alternatives: CRISPR opportunities and challenges
Wang, F., Liu, X., Gu, W., Xie, X., Wu, S., Gao, S., Srimongkol, P., Srinuanpan, S., Karnchanatat, A., & Gu, W. (2026) · Bioresource Technology · doi:10.1016/j.biortech.2026.135918
CRISPR-Based Genome Editing and Delivery Systems: Advances, Challenges and Future Directions
Kaur, A., Chanan, R., Sharma, M., Sharma, S., & Sharma, D. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016405
Gao, H., Fu, W., Li, R., Chen, H., Zhang, Q., & Zhang, Z. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.106126
Metadata
- Authors
- Zischewski, J., Fischer, R., & Bortesi, L.
- Affiliations
- RWTH Aachen University (DE)
- Fraunhofer Institute for Molecular Biology and Applied Ecology (DE)
- Corresponding author
- Bortesi, Luisa
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 35
- Issue
- 1
- Pages
- 95-104
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2565555627
- Cited by
- 323
- References
- 78
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 32 · 2023: 31 · 2022: 35 · 2021: 41 · 2020: 40 · 2019: 46 · 2018: 37 · 2017: 18
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biotechnology Advances (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- RWTH Publications (RWTH Aachen) (publishedVersion, other-oa)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Funders
- European Research Council (269110)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- CRISPR/Cas9, off-target mutations, TALEN, zinc finger nucleases, sequence-specific nucleases, genome editing, sensitivity
- MeSH terms
- Gene Editing, Animals, Base Sequence, Cell Line, Deoxyribonucleases, Humans, Mutation, Mice, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
